Teligent
TLGT
#10190
Rank
ยฃ11.96 M
Marketcap
ยฃ0.13
Share price
-13.85%
Change (1 day)
1,497.55%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Revenue for Teligent (TLGT)

Revenue in 2021 (TTM): ยฃ34.34 Million

According to Teligent's latest financial reports the company's current revenue is ยฃ34.39 Million. In 2020 the company made a revenue of ยฃ33.65 Million a decrease over the revenue in the year 2019 that were of ยฃ48.95 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Teligent from 2001 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)ยฃ34.34 M2.02%
2020ยฃ33.65 M-31.24%
2019ยฃ48.95 M-0.71%
2018ยฃ49.3 M-1.31%
2017ยฃ49.95 M0.55%
2016ยฃ49.68 M51.14%
2015ยฃ32.87 M31.15%
2014ยฃ25.06 M85.15%
2013ยฃ13.53 M112.81%
2012ยฃ6.36 M9.7%
2011ยฃ5.79 M28.07%
2010ยฃ4.52 M61.33%
2009ยฃ2.8 M-7.15%
2008ยฃ3.02 M-11.18%
2007ยฃ3.4 M74.85%
2006ยฃ1.94 M-8.62%
2005ยฃ2.12 M-8.84%
2004ยฃ2.33 M-11.58%
2003ยฃ2.64 M-51.95%
2002ยฃ5.49 M-54.52%
2001ยฃ12.09 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
ยฃ0.47 B 1,286.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
ยฃ0.16 M-99.51%๐Ÿ‡บ๐Ÿ‡ธ USA